Navan Ward in the News

Photo of Navan Ward Navan Ward , Jr.
Lead Attorney in DePuy Hip Recall Litigation
 

Articles 81 to 90 of 96 for attorney Navan Ward .

New Orleans Jury Returns $51 Million Verdict against Merck

| August 17, 2006
A New Orleans jury in the second Multi-District Litigation (MDL) trial has awarded a $50 million compensatory damage verdict and a $1 million punitive damage verdict against Merck.

Update on Vioxx and Celebrex Litigation

| March 9, 2006
Merck tried its best to hide the fatal risks of taking Vioxx and aggressively marketed the drug to drown out any questions about safety.

Celebrex Case Set for Trial in Alabama State Court

| March 1, 2006
A Celebrex lawsuit has been set for trial on June 6, 2006 for a woman who suffered a stroke at age 53, caused by taking the pain relieving drug, Celebrex. The trial will take place in the Circuit Court of Barbour County in Alabama. It will most likely be the first Celebrex case to be tried in the country.

Bextra's Return Barred by Health Canada

| December 17, 2005
Bextra is a member of a class of drugs known as cox-2 inhibitors. Better known cox-2s are Celebrex, which is still sold, and Vioxx, which was pulled from worldwide markets in September 2004.

U.S. Vioxx case retrial set for Feb. 6

Reuters | December 16, 2005
NEW YORK, Dec 16 (Reuters) -The first federal trial against Merck & Co and its withdrawn painkiller Vioxx, which ended in a mistrial earlier this week, will be retried on February 6 in New Orleans, representatives of both sides said on Friday.

More Deaths Reported to FDA after Guidant Recall

| December 15, 2005
Recent reports have surfaced about new patient deaths associated with fatal complications from heart devices manufactured by Guidant Corporation.

FDA Rejects Bextra-Like Drug

| September 20, 2005
The FDA has decided not to approve a special formulation of Pfizer's recalled pain reliever Bextra that was to be used to treat pain following surgery.

Beasley fighting drug Company

| June 10, 2005
The law firm of Barbour County native Jere Beasley is representing an Alabama resident who is suing New Jersey-based Wyeth Pharmaceuticals and Alabama-based Qualitist for allegedly causing physical injury, including breast cancer.

Beasley files hormone drug suit

Clayton Record | June 9, 2005
Bullock County Circuit court in Union Springs will be the venue for the state's first lawsuit against pharmaceutical manufacturers of three hormone therapy drugs.

FDA Issues Alert to Crestor Users

| March 2, 2005
Crestor is being revised to highlight important information on the safe use of Crestor to reduce the risk for serious muscle toxicity (myopathy/rhabdomyolysis), especially at the highest approved dose of 40 mg.